6485 — Maezawa Kyuso Industries Co Balance Sheet
0.000.00%
- ¥26bn
- ¥16bn
- ¥32bn
- 97
- 81
- 47
- 89
Annual balance sheet for Maezawa Kyuso Industries Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 14,085 | 14,700 | 11,636 | 10,845 | 10,323 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 10,131 | 10,597 | 11,261 | 12,302 | 10,919 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 29,830 | 31,806 | 30,675 | 30,706 | 29,934 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,602 | 7,518 | 7,708 | 7,861 | 7,840 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 44,040 | 45,619 | 44,643 | 45,965 | 45,777 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6,745 | 7,121 | 5,602 | 5,712 | 5,006 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 7,628 | 7,989 | 6,418 | 6,926 | 6,024 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 36,412 | 37,630 | 38,225 | 39,039 | 39,753 |
Total Liabilities & Shareholders' Equity | 44,040 | 45,619 | 44,643 | 45,965 | 45,777 |
Total Common Shares Outstanding |